Department of Medicine, Columbia Center for Translational Immunology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Xenotransplantation. 2021 Jul;28(4):e12691. doi: 10.1111/xen.12691. Epub 2021 Apr 26.
A major obstacle to the success of organ transplantation from pigs to humans, necessitated by the shortage of human organs, is robust humoral immune rejection by pig-reactive human antibodies. Mixed xenogeneic hematopoietic chimerism induces xenoreactive B cell tolerance in rodents, but whether mixed pig/human chimerism could induce tolerance of human B cells to pig xenoantigens is unknown.
We investigated this question using a humanized mouse model in which durable mixed (pig-human) xenogeneic chimerism can be established.
Human natural anti-pig cytotoxic antibodies, predominantly IgM, are detectable in non-chimeric humanized mouse serum, and pig-reactive antibodies were reduced in mixed chimeric versus non-chimeric humanized mice. This difference required persistent mixed chimerism and was not due to the adsorption of antibodies on pig cells in vivo. Furthermore, human B cells from spleens of mixed chimeric mice produced lower levels of anti-pig antibodies when stimulated in vitro compared with those from non-chimeric mice.
Our findings demonstrate that mixed chimerism reduces human natural antibodies to pig xenoantigens, providing the first in vivo evidence of human B cell tolerance induction by mixed xenogeneic chimerism and supporting further evaluation of this approach for inducing human B cell tolerance to xenografts.
由于人类器官短缺,猪到人体器官移植的成功面临一个主要障碍,即猪反应性人抗体引起的强烈体液免疫排斥。混合异种造血嵌合体在啮齿动物中诱导异种反应性 B 细胞耐受,但混合猪/人嵌合体是否能诱导人 B 细胞对猪异种抗原的耐受尚不清楚。
我们使用一种人源化小鼠模型来研究这个问题,该模型可以建立持久的混合(猪-人)异种嵌合体。
非嵌合人源化小鼠血清中可检测到人类天然抗猪细胞毒性抗体,主要为 IgM,而混合嵌合与非嵌合人源化小鼠相比,猪反应性抗体减少。这种差异需要持续的混合嵌合体,而不是体内抗体在猪细胞上的吸附。此外,与非嵌合小鼠相比,来自混合嵌合小鼠脾脏的人 B 细胞在体外刺激时产生的抗猪抗体水平较低。
我们的研究结果表明,混合嵌合体减少了人类对猪异种抗原的天然抗体,为混合异种嵌合体诱导人 B 细胞耐受提供了体内证据支持,支持进一步评估这种方法诱导人 B 细胞对异种移植物的耐受。